Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients.
Journal: Leukemia & lymphoma
Published: May 18, 2026
SOHO State of the Art Updates and Next Questions | Progress in Clonal Hematopoiesis of Indeterminate Potential/Clonal Cytopenia of Uncertain Significance.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 16, 2026
Molecular approach to cytopenia and bone marrow failure.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Concomitant or sequential lower intensity triplet therapy in AML.
Journal: The Lancet. Haematology
Published: November 21, 2025
Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: October 04, 2022
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.
Journal: Open forum infectious diseases
Published: December 22, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Journal: Cancer
Published: October 25, 2021
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Journal: Clinical genitourinary cancer
Published: October 22, 2021
Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma.
Journal: Frontiers in oncology
Published: September 30, 2021
Last Updated: 09/26/2026